Clinical Trials
8
Active:2
Completed:2
Trial Phases
3 Phases
Phase 1:1
Phase 4:1
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (60.0%)Phase 1
1 (20.0%)Phase 4
1 (20.0%)Dermal HIV-1 Immunization During Anti-retroviral Therapy Followed by Repeated Treatment Interruptions
Phase 1
Completed
- Conditions
- HIV-1
- First Posted Date
- 2010-06-09
- Last Posted Date
- 2010-06-09
- Lead Sponsor
- Swedish Institute for Infectious Disease Control
- Target Recruit Count
- 12
- Registration Number
- NCT01140139
- Locations
- 🇸🇪
South Hospital, Stockholm, Sweden
Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease
- Conditions
- PolioTetanusDiphtheriaMeaslesHepatitis BPertussisHaemophilus Influenzae Type BMumpsRubella
- First Posted Date
- 2009-07-03
- Last Posted Date
- 2009-07-03
- Lead Sponsor
- Swedish Institute for Infectious Disease Control
- Target Recruit Count
- 5400
- Registration Number
- NCT00932269
- Locations
- 🇸🇪
Swedish Institute for Infectious Disease Control, Solna, Sweden
An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
Phase 4
- Conditions
- DiphtheriaPertussisTetanus
- First Posted Date
- 2009-03-27
- Last Posted Date
- 2010-06-07
- Lead Sponsor
- Swedish Institute for Infectious Disease Control
- Target Recruit Count
- 400
- Registration Number
- NCT00870350
- Locations
- 🇸🇪
Swedish Institute for Infectious Disease Control, Lund, Sweden
News
No news found